University of Dundee, MSc Human Clinical Embryology and Assisted Conception - Apply now for September 2018
Page URL: https://www.bionews.org.uk/page_94179

UK Government backs mitochondrial replacement

1 July 2013
Appeared in BioNews 711

The UK Government is to support the introduction of mitochondrial replacement therapy. The IVF-based procedure could allow women with mitochondrial disease the opportunity to have healthy children, by replacing their own, faulty mitochondria with healthy mitochondria from a donor.

The Chief Medical Officer, Dame Sally Davies, said: 'What we are starting to do now is to develop the regulations, consult on these regulations and then to take them into Parliament… I hope then to go forward and we'll be the first country if we do'.

UK law currently prohibits a genetically altered human embryo from being implanted into a woman, but the Secretary of State has the power to introduce regulations to permit treatment in specified circumstances for the prevention of serious mitochondrial disease. The draft regulations would need to be approved by both Houses of Parliament before they can become law.

Mitochondrial DNA replacement techniques have raised a number of ethical considerations, because they require the use of genetic material from a third person, the mitochondrial DNA donor, leading to children born with genetic material from three people. Furthermore, replacing diseased mitochondria with healthy ones would be a change that would be passed on to subsequent generations. This could constitute a form of germ-line therapy.

However, Professor Davies explained that it is only the germ-line of the mitochondria that is passed down to future generations, which is quite separate from the DNA of the nucleus that 'makes us what we are'. 'There is no intention of doing anything with the nuclear DNA', she said.

The UK's Human Fertilisation and Embryology Authority (HFEA), which supports the introduction of regulations to Parliament, advised the Government there is no scientific evidence to suggest the proposed techniques are unsafe. It also conducted a public consultation in 2012 that showed broad support for the treatment. A review by a British Medical Association's medical ethics committee last year also decided that the treatments were ethical and should go ahead, as long as research suggests they are likely to be safe and effective. The Nuffield Council on Bioethics also concluded that the future use of and continued research into such treatments would be ethically permissible.

Professor Alison Murdoch from Newcastle University, which is leading the way with research into mitochondrial replacement therapy, said in the Independent: 'This is great news for UK science and gives hope to women who just want a healthy baby. The UK Government has made a moral decision. There is still more research to do, but this decision means that we could eventually be allowed to offer it as a treatment'.

There are currently two mitochondrial replacement techniques in development, both of which involve transferring the nuclear DNA of the future parents into a donor egg containing healthy mitochondria. 'Pronuclear transfer' involves taking the nucleus of a fertilised egg containing DNA from both the father and mother, and transferring it into a donor egg in which the nucleus has been removed. In the alternative method, 'maternal spindle transfer', the mother's DNA is transferred to the donor egg before it is fertilised. The treatments have been shown to be effective in animals but could not be fully tested in humans without changes made by Parliament.

Speaking to The Guardian, Professor Robin Lovell-Badge from the National Institute for Medical Research said, 'it will of course be a brave decision for the first families, and for the HFEA as the regulator, to decide to go ahead once the regulations are approved by Parliament, but more often than not, progress requires some element of bravery'.

Sarah Norcross of the Progress Educational Trust, the organisation that publishes BioNews, said: 'UK scientists are leading the way with their research to avoid inherited mitochondrial diseases and the UK Government is emulating them'.

'The combination of the regulatory framework already in place for IVF and the public support for the techniques to be allowed means that the Government can act confidently and quickly and not impede scientific progress from delivering its promised benefit', she added.

The regulations are due to be debated in Parliament next year.

SOURCES & REFERENCES
A bold step for science and society
BBC News |  28 June 2013
Britain plans world's first go-ahead for '3-parent' IVF babies
Reuters |  28 June 2013
Three-person IVF: UK government backs mitochondrial transfer
The Guardian |  28 June 2013
UK becomes first country in world to approve IVF using genes of three parents
The Independent |  28 June 2013
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
28 July 2014 - by Dr Rachel Brown 
The UK Government has announced that regulations around the use of mitochondrial replacement techniques will be presented to Parliament in the next few months...
3 March 2014 - by Patricia Cassidy 
The UK Department of Health has published draft guidelines for the use of new techniques to prevent mothers passing on serious mitochondrial diseases to their children. The guidelines will be the subject of a three-month consultation...
3 March 2014 - by Chee Hoe Low 
The USA's Food and Drug Administration (FDA) is considering whether to allow human clinical trials of mitochondrial replacement, an IVF technique that uses gametes from three people...
27 January 2014 - by Sarah Norcross 
PET is delighted to receive a testimonial from John Harris, professor of bioethics at the University of Manchester...
20 January 2014 - by Professor Sandy Raeburn 
Having worked with families affected by genetic disorders for more than 40 years, both in the UK (with its multi-faith society) and in the Sultanate of Oman (where the majority are Muslim but other religions are allowed), I have seen and looked after many people with hereditary illnesses, including those with disabling mitochondrial conditions....
6 January 2014 - by Dr Calum MacKellar 
Mitochondrial replacement techniques are not a form of therapy in which a person is being treated or cured for a disorder, but instead make sure that that certain persons are not brought into existence. This is a crucial difference since it then questions the equality in value and worth of every possible future person...
16 December 2013 - by Antony Blackburn-Starza 
The Human Fertilisation and Embryology Authority has announced the appointment of Sally Cheshire as its interim chair when Professor Lisa Jardine's term as chair comes to an end in January 2014....
2 December 2013 - by Dr John Appleby, Professor Rosamund Scott and Professor Stephen Wilkinson 
A group of European parliamentarians from the Council of Europe recently issued a declaration objecting to the HFEA's policy advice on experimental mitochondrial replacement therapy claiming that MRT is eugenic and inconsistent with human dignity. These are substantial moral claims, ones that deserve closer scrutiny, and it is an interesting and important exercise to consider how successful such arguments are...
21 October 2013 - by Ruth Saunders 
The health regulator in the USA is considering whether clinical trials of mitochondrial replacement techniques should go ahead....
14 October 2013 - by Dr Rosie Gilchrist 
A group of European parliamentarians has criticised UK proposals to legislate for mitochondrial replacement therapy, calling it 'a eugenic practice'...
23 September 2013 - by Dr Rosie Gilchrist 
A group of scientists has expressed concerns that it may be too soon to bring mitochondrial replacement techniques, which are still under development, to the clinic....
22 July 2013 - by Professor Stephen Wilkinson 
Why are potentially positive developments like mitochondrial replacement therapy and next-generation sequencing greeted with talk of 'designer babies', and is such language justified?
21 March 2013 - by Sandy Starr 
Mitochondrial replacement therapy, where a small amount of a mother's genetic material is swapped with material from a donor during IVF to avoid passing on heritable illnesses, enjoys the 'general support' of the public, the UK's fertility regulator says...
19 November 2012 - by Professor Mary Herbert 
The energy required for our cells to function properly is mainly produced by mitochondria. Mitochondria are tiny structures within our cells, which contain their own DNA. The mitochondrial DNA (mtDNA) encodes a small number of the many proteins required to produce energy efficiently. Mutations in mtDNA cause a broad spectrum of diseases and degenerative disorders, which can be fatal....
29 October 2012 - by Joseph Jebelli 
Scientists have successfully created human embryos containing donated mitochondrial DNA in an effort to stop children inheriting life-threatening diseases...
17 September 2012 - by Dr Sophie Pryor 
The UK's Human Fertilisation and Embryology Authority (HFEA) has launched a public consultation on the social and ethical impact of new methods that could prevent the transmission of some incurable mitochondrial diseases....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.